GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.75 $4.97 Thursday, 18th Apr 2024 ALDX stock ended at $3.98. This is 0.252% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 4.63% from a day low at $3.89 to a day high of $4.07.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2020-08-13 $6.75 $6.85 $6.57 $6.74 371 932
2020-08-12 $6.62 $6.91 $6.50 $6.72 608 423
2020-08-11 $6.91 $6.98 $6.55 $6.61 818 011
2020-08-10 $7.29 $7.54 $6.83 $6.89 701 259
2020-08-07 $6.70 $7.36 $6.70 $7.13 565 570
2020-08-06 $7.01 $7.20 $6.51 $6.76 1 314 649
2020-08-05 $6.74 $7.74 $6.74 $7.46 1 851 466
2020-08-04 $6.49 $6.89 $6.45 $6.77 520 343
2020-08-03 $6.46 $6.61 $6.29 $6.55 551 068
2020-07-31 $6.88 $6.95 $6.25 $6.43 1 415 867
2020-07-30 $6.12 $6.93 $6.10 $6.87 835 322
2020-07-29 $6.55 $6.68 $6.09 $6.33 1 189 697
2020-07-28 $6.71 $6.95 $6.48 $6.50 799 999
2020-07-27 $7.09 $7.10 $6.32 $6.77 1 455 183
2020-07-24 $6.49 $7.15 $6.30 $6.98 2 063 712
2020-07-23 $6.52 $6.60 $6.01 $6.33 945 114
2020-07-22 $6.08 $6.77 $6.08 $6.49 927 000
2020-07-21 $6.66 $6.75 $6.09 $6.10 1 100 500
2020-07-20 $6.70 $6.85 $6.15 $6.53 987 400
2020-07-17 $6.61 $7.00 $6.45 $6.68 1 746 900
2020-07-16 $5.72 $6.52 $5.66 $6.42 1 640 100
2020-07-15 $5.70 $5.89 $5.46 $5.83 1 200 200
2020-07-14 $5.15 $6.05 $5.02 $5.70 4 683 200
2020-07-13 $5.11 $5.32 $4.68 $4.70 1 486 700
2020-07-10 $5.07 $5.55 $4.79 $4.82 2 173 900
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT